Merck & Co. (MRK)
(Delayed Data from NYSE)
$130.72 USD
+3.72 (2.93%)
Updated Apr 25, 2024 04:02 PM ET
After-Market: $131.00 +0.28 (0.21%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth D Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/06/2024
Time: -- |
6/2024 | $2.16 | 1.51% |
Earnings Summary
For their last quarter, Merck & Co. (MRK) reported earnings of $2.07 per share, beating the Zacks Consensus Estimate of $1.94 per share. This reflects a positive earnings surprise of 6.70%. Look out for MRK's next earnings release expected on August 06, 2024. For the next earning release, we expect the company to report earnings of $2.16 per share, reflecting a year-over-year increase of 204.85%.
Earnings History
Price & Consensus
Zacks News for MRK
Merck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales
MRK: What are Zacks experts saying now?
Zacks Private Portfolio Services